Company Overview and News

37
Wall Street to open higher as tech bounces back

1h channelnewsasia
U.S. stock index futures pointed to a higher opening on Thursday, extending a bounce since the latest blows in the U.S.-China trade spat this week on the back of a recovery for technology stocks.
UA GEC GE UAA DRI GNE AMD RHT

37
US STOCKS-Wall St to open higher as tech bounces back

1h reuters
(Reuters) - U.S. stock index futures pointed to a higher opening on Thursday, extending a bounce since the latest blows in the U.S.-China trade spat this week on the back of a recovery for technology stocks.
UA GEC GE UAA DRI GNE AMD RHT

1
Darden Restaurants (DRI) Tops Q1 Earnings and Revenue Estimates

1h zacks
Darden Restaurants (DRI - Free Report) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.99 per share a year ago. These figures are adjusted for non-recurring items.
SIR DRI HAYN LB

42
Stocks making the biggest move premarket: DRI, THO, GE, CAT, PG & more

2h cnbc
Darden Restaurants – The parent of Olive Garden, Longhorn Steakhouse, and other restaurant chains earned $1.34 per share for its latest quarter, 10 cents a share above estimates. Revenue beat forecasts, as well. Darden's comparable-restaurant sales rose 3.3 percent, tripling consensus estimates, and it also raised its full-year outlook.
WFCNP RIO RIO RL WBA DRI SFIX RTPPF RTNTF DIS WFC GEC GE THO RHT RIO MLHR GNE

 
iPic Entertainment - Grab Some Popcorn

2h seekingalpha
The company ended Q2 with just $6.6 million cash, -$11.7 million working capital, and -$173 million shareholder equity.
IPIC DRI

 
Olive Garden parent Darden's stock jumps toward record after profit and sales beat, raised outlook

3h marketwatch
Shares of Darden Restaurants rallied 4.3% toward a record high in premarket trade Thursday, after the parent of Olive Garden and LongHorn Steakhouse restaurant chains beat fiscal first-quarter profit and sales expectations and raised its full-year outlook. Net income for the quarter to Aug. 26 rose to $166.2 million, or $1.32 a share, from $119.0 million, or 93 cents a share, in the same period a year ago.
DRI

2
Forget J. C. Penney (JCP), Buy These 3 Retail Stocks Instead

22h zacks
Shares of J. C. Penney Company, Inc. (JCP - Free Report) have slumped 38.5% in the past six months against the Retail-Regional Department Stores industry and the Retail Whole Sector’s rally of 17.5% and 8.7%, respectively. Industry experts cited failed leadership, high debt and dismal second-quarter results as the reasons behind the same. Also, the company’s muted fiscal 2018 view added to investors’ woes.
TGT UNP DRI

 
Cost-Saving Initiatives to Boost Darden's (DRI) Q1 Earnings

2018-09-19 zacks
Darden Restaurants, Inc. (DRI - Free Report) is set to report first-quarter fiscal 2019 results on Sep 20, before the opening bell.
DRI

66
15 Best S&P 500 Stocks to Buy as the Markets Heat Up

2018-09-19 investorplace
One of the more popular strategies among investors today is to seek out “home runs.” These are lesser-known companies that have tremendous upside potential, but carry the risk of collapsing should business prospects go awry. While a balanced portfolio allows for some speculation, now is also a great time to consider S&P 500 stocks.
LMT HD EA FB UPS MA DRI FDX BBY HOG GT V AMZN CVX RTN ABBV HPQ MO

6
Brinker (EAT) Stock Up 31% in 6 Months: Can it Gain Further?

2018-09-18 zacks
Shares of Brinker International, Inc. (EAT - Free Report) have surged 30.7% in the past six months, outperforming the industry’s 1.9% growth. The outperformance can be attributed to expansion and sales-building initiatives along with increased investments in technology and continual focus on take-out businesses. However, a slowdown in some key international markets and overall high costs associated with restaurant operations might hurt its profitability in the future.
EAT TXN RUTH MDPEB DRI MDP

8
Soft August Retail Sales a Temporary Hitch? 5 Stocks to Buy

2018-09-17 zacks
U.S. retail sales showed continued rise going into August but the rate of growth fairly moderated, as bargain hunters took a breather after an extravagant July. As Americans refrained from splurging on automobiles and apparel, retail sales showed a slight uptick in six months. Analysts also cited high gasoline prices as one of the prominent reasons behind soft sales in other categories. Nevertheless, an upwardly revised July sales data suggests that the economy is firm, given solid labor market, tax reform and rising income.
TGT BURL DSW DRI URBN

1
BJ's Restaurants Rallies 155% in a Year: More Gains in Store?

2018-09-17 zacks
BJ's Restaurants, Inc.’s (BJRI - Free Report) sales-building initiatives, enhanced loyalty program, improved comps and operating margins have been perking up investors. Buoyed by these, the stock has gained a significant 154.7% in a year’s time, outperforming the industry’s rise of 7%. However, high cost of sales and slowdown in new restaurant opening are concerning. Catalysts Driving Growth BJ's Restaurants’ continuous focus on productivity and efficiency along with implementation of several major sales-building initiatives are major drivers of its top line.
BJRI RUTH DRI

 
US stocks edge lower amid more trade tariff worries

2018-09-17 nzherald.co.nz
U.S. stocks edged lower in early trading Monday amid speculation that the Trump administration is preparing to impose tariffs on another $200 billion-worth of Chinese goods. Technology stocks, retailers and restaurant chains were among the decliners. Energy stocks rose along with crude oil prices.
NDAQ DRI CMG

 
Dave & Buster's (PLAY) in Focus: Stock Moves 7.9% Higher

2018-09-17 zacks
Dave & Buster's Entertainment, Inc. (PLAY - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 15.9% in the past one-month time frame.
DRI PLAY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to DRI / Darden Restaurants, Inc. on message board site Silicon Investor.

Madrigal Pharmaceuticals Madrigal Pharmaceuticals Madrigal Pharmaceuticals Driverless autos, trucks, taxis etc. Driverless autos, trucks, taxis etc. Driverless autos, trucks, taxis etc.
Mr. Pinku0027s Picks: selected event-driven value investments Mr. Pinku0027s Picks: selected event-driven value investments Mr. Pinku0027s Picks: selected event-driven value investments seadrill SDRL seadrill SDRL seadrill SDRL
Drinking Water - EPA and Arsenic Drinking Water - EPA and Arsenic Drinking Water - EPA and Arsenic EQ Sports drinks EQ Sports drinks EQ Sports drinks
Parker Drilling Co. Parker Drilling Co. Parker Drilling Co. Hemp drinks Hemp drinks Hemp drinks
NE, Noble Drilling NE, Noble Drilling NE, Noble Drilling Drinks Americas Drinks Americas Drinks Americas
CUSIP: 237194105